亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Selective Neuronal Nitric Oxide Synthase Inhibitors for the Treatment of Human Melanoma

技术优势
New means of diagnosisPotential melanoma prophylactic
详细技术说明
Novel compound that inhibits nitric oxide synthase, a key oxidative stress mediator in human melanoma.#diagnostic #cancer #therapeutics
*Abstract

UV radiation exposure, especially sunburn at a young age, is commonly linked to melanoma incidence. As an important environmental carcinogen, UV radiation not only generates reactive oxygen species but also produces a large amount of nitric oxide (NO) in human skin.  Upon NO stress by the NO donor DETA, both melanoma proliferation and invasion potential are both significantly stimulated.  Northwestern researchers have identified a neural NO synthase (nNOS) that demonstrates an important role in generating NO and mediating NO stress in human melanoma.  They have studied the effects on nNOS in vitro cell culture and in vivo human biopsy studies.  More interestingly, they discovered that an induction of nNOS was evident with UVB radiation and basic fibroblast growth factor (bFGF) incubation. Conversely, knockdown of nNOS with siRNA efficiently reduced the DETA-induced melanoma proliferation and invasion potential.  A novel synthesized nNOS inhibitor, JI-11, has been identified to inhibit nNOS activity.  Results show that co-treatment with JI-11 significantly attenuated the alterations induced by UVB radiation and DETA treatments.  These studies represent an innovative and promising strategy for melanoma prevention.

*Inventors
Haitao Mark Ji Frank L Meyskens, Jr. Thomas L. Poulos Richard B. Silverman * Fengtian Xue Sun Yang
*Publications
Antioxidants & Redox Signaling. 2013;19(5):433-447
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备